qEEG · NON INVASIVE

Quantitative EEG (qEEG)

Spectrograms, alpha-delta ratio, suppression burst ratio, and the data-reduction layer that turns continuous EEG into trends a non-neurophysiologist can read at the bedside.

ElectricalBedside + researchPeds + adultNon-invasiveEmerging
BLast reviewed 2026-05-1718-min read

1. Bedside vignettes: why this matters in the PICU

Vignette A. SAH day 6, ADR falling

A 14-year-old is on day 6 after a ruptured AVM with secondary SAH. The clinical exam is unchanged, the daily TCD is borderline (MFV 140, Lindegaard 2.8), and ICP is well controlled. The cEEG / qEEG technologist updates the DSA: over the last 6 hours, the right hemisphere ADR has fallen from 0.42 to 0.28, a 33% drop. Total power on the right is stable; the asymmetry index has crossed the 0.3 alert threshold. There is no overt clinical sign. The team escalates: triple-H haemodynamics, repeat CT angio, and decision-prep for endovascular treatment. The qEEG caught the ischaemic signature 12 hours before the next angio confirmed early vasospasm progression.

Vignette B. Neonatal seizure burden on cEEG / qEEG

A 5-day-old term infant with HIE on day 3 of normothermic rewarming is on cEEG. The bedside DSA shows three discrete bright vertical "fingers" (each 2 to 4 minutes long) over the last hour, occupying about 20% of the trace. The amplitude-integrated EEG (aEEG) trace shows abrupt elevations in the upper margin during the same intervals. These are electrographic seizures, recurrent and meeting the ACNS quantitative definition of neonatal status epilepticus (> 50% of any 1 h epoch). Treatment is escalated from phenobarbital to phenytoin then to midazolam infusion with bedside DSA / aEEG endpoints.

Vignette C. Sedated TBI with paradoxically high ADR

A 12-year-old with severe TBI is on continuous midazolam and fentanyl, ICP 18 mmHg, BIS 35. The cEEG is markedly suppressed with intermittent bursts. The bedside DSA shows a fairly bright "alpha band" (8 to 13 Hz) at all leads, and the ADR is 0.6 (high). The neurophysiologist explains: this is not preserved alpha-rhythm-of-arousal, but a sedative-induced anterior alpha pattern (propofol- and benzodiazepine-induced frontal alpha), and the ADR here is uninformative about cortical metabolism. qEEG values must always be interpreted with knowledge of sedation, age, and the raw EEG context.


2. What qEEG is, and what it is not

Continuous EEG (cEEG) generates roughly 24 channels × 256 Hz × 86,400 s = ~500 million samples per day. A neurophysiologist cannot scan this volume of raw EEG continuously, and a bedside nurse or intensivist usually cannot read raw EEG at all. qEEG is the family of data-reduction algorithms that turn this firehose into a manageable, trendable bedside display.

The key qEEG outputs.

  • DSA (density spectral array): a colour-coded time-frequency map per channel. Time on the x-axis (typically the last 6 to 24 h), frequency on the y-axis (0 to 30 Hz), power encoded as colour intensity. The single most useful qEEG display.
  • ADR (alpha-delta ratio): instantaneous ratio of 8 to 13 Hz power to 1 to 4 Hz power. Falls with cortical ischaemia (alpha disappears, delta predominates). The most validated qEEG metric for DCI detection in SAH.
  • BSR (burst suppression ratio) / PSI (power suppression index): proportion of time spent in low-amplitude suppression. Used for sedation titration (BSR 30 to 60% is a common target in pentobarbital coma) and post-arrest prognostication.
  • Total power: amplitude in microvolts across the whole spectrum. Falls during global ischaemia or deep sedation.
  • Asymmetry index: difference in spectral power between the hemispheres; rises with unilateral lesion or ischaemia.
  • SEF95: frequency below which 95% of power lies; falls in slowed EEG (sedation, encephalopathy, ischaemia).

Three things follow.

qEEG does not replace raw EEG review. Artefact (chewing, sweat, electrode pop, infusion-pump 60 Hz noise) can dominate qEEG metrics. A neurophysiologist must validate the raw trace at least daily and flag artefacts. qEEG metrics in isolation can mislead.

qEEG amplifies what raw EEG already shows. The DSA reveals trends (slow drift in ADR, asymmetry building over hours, recurrence of seizures in the night) that are invisible to short single-snapshot raw-EEG reads.

Pediatric qEEG requires pediatric-aware interpretation. Normal pediatric EEG is faster (alpha frequency rises through childhood, peaking at ~10 Hz by mid-school age), so the "alpha band" in a 6-month-old is centred lower than in a 12-year-old. Suppression patterns and burst morphology also differ.

Clinical pearl

ADR is the most useful single qEEG metric in the PICU. A 25 to 50% drop in ADR over 6 hours, sustained, in a patient with SAH, severe TBI, or any acute ischaemic risk, is a strong signal to look harder (clinical exam, TCD, imaging). The single absolute value is less informative than the trend.

In children

Pediatric cEEG / qEEG is the standard of care for neonatal seizure surveillance (ACNS 2021 guidelines). All neonates at risk (HIE, suspected encephalopathy, post-cardiac surgery, post-arrest) should have cEEG with qEEG / aEEG bedside displays for at least 24 hours.


3. Anatomy and montage: the substrate of qEEG

Fig. 1
qEEG: MONTAGE + DSA PREVIEWeach bipolar channel feeds a time-frequency analysis to produce its own DSA row(left) 10-20 bipolar montageFp1F3C3P3O1left chain: Fp1-F3-C3-P3-O1 (Cz ref)(right) DSA preview (~24 channels)seizuretime →RLbright band = seizures · HF loss = encephalopathy · L-R colour = asymmetryMNM-Edu schematic · DSA colours are schematic, not live data
Standard pediatric 10 to 20 montage with bipolar chains (Cz reference) and density spectral array preview. Bipolar montage on the left: Fp1-F3, F3-C3, C3-P3, P3-O1 (left chain) and analogous right chain; transverse and circumferential chains add detail. Each channel feeds a continuous time-frequency analysis (FFT or short-time Fourier or wavelet) to produce its own DSA row. The composite DSA on the right shows ~24 channels stacked, with time on x and frequency on y per channel; bright vertical bands are recurrent seizures, gradual loss of high frequencies is encephalopathy, hemispheric asymmetry is left-vs-right colour difference.
MNM-Edu, original schematic.

The qEEG display sits on top of a properly placed multi-channel EEG. Three practical layers:

  1. Electrode placement: international 10-20 system (or 10-10 in research / refractory work). Most pediatric ICU recordings use 16 to 21 electrodes. Neonatal montages often use a reduced "neonatal montage" (~10 electrodes) per ACNS 2013 guidelines.
  2. Reference: a reference electrode is needed for monopolar montages (Cz / linked-ears / average reference). Bipolar montages subtract adjacent pairs and are reference-independent.
  3. Computation: the qEEG software computes the desired metrics (DSA, ADR, BSR, SEF, asymmetry) in 2 to 10 s epochs and updates the display in near real time.

Skin preparation is the single biggest determinant of trace quality. Electrode impedance < 5 kΩ at every channel is the goal. Sub-optimal prep gives artefact-laden traces whose qEEG metrics are uninterpretable.


4. The DSA: anatomy of a spectrogram

Fig. 2
qEEG DSA + ALPHA-DELTA RATIO (SAH day 6)right alpha dims + delta rises; ADR falls 0.42 to 0.22 and crosses the 0.3 alertright hemispherealphadeltaleft hemispherealphadeltafreq 0-25 Hzalpha-delta ratio (ADR)0.00.10.20.30.40.50.3 alertleft ~0.40 (stable)right (affected)0.420.280.22036912time (hours)MNM-Edu schematic
A 12-hour density spectral array (DSA) of a SAH day 6 patient. X-axis: time. Y-axis per channel: frequency 0 to 25 Hz. Colour: log power. Top panels show the right hemisphere; bottom show left. At hour 0, both hemispheres show moderate alpha (8 to 13 Hz, yellow band) and modest delta (1 to 4 Hz). By hour 6, the right hemisphere alpha has dimmed, delta has risen, and the ADR has fallen from 0.42 to 0.28; the left is stable at 0.40. By hour 9, the right ADR is 0.22 and the asymmetry has crossed the alert threshold of 0.3. Confirmatory TCD and angio follow.
MNM-Edu, original schematic.

How to read a DSA at the bedside.

  1. Look at the colour gradient: bright yellow / red = high power, dark blue = low power.
  2. Bands of horizontal colour correspond to dominant frequency bands. A bright band at 8 to 13 Hz is alpha, 4 to 7 Hz is theta, 1 to 4 Hz is delta, 13 to 30 Hz is beta.
  3. Vertical bright stripes are typically seizures (rhythmic activity across all frequencies for a short time).
  4. Slow drift in colour over hours is the most diagnostically interesting signal: a gradual loss of high-frequency colour is encephalopathy; a gradual asymmetry building over hours is unilateral ischaemia; a recovering bright alpha band post-arrest is reassuring.
  5. Asymmetry between hemispheric panels is the focal-ischaemia signal.

The four common qEEG metrics on a single screen.

MetricWhat it tracksNormalAbnormal
ADRCortical metabolism / arousal0.4 to 0.6 (awake adult)< 0.3, or 25 to 50% drop over 6 h
BSR / PSIBurst suppression / sedation depth0%30 to 60% (target for pentobarbital coma); > 80% post-arrest = poor prognosis
Total powerGlobal EEG amplitudeAge-band specific< 5 µV² = severe suppression
AsymmetryHemispheric difference< 0.2> 0.3

5. The numbers: what to record at the bedside

VariableSymbolWhat it tells you
Alpha-delta ratioADR (per side)Cortical metabolism, ischaemia detection
Suppression / burst suppression ratioBSR or PSI (%)Sedation depth; post-arrest prognosis
Total spectral powerTSP (µV²)Global EEG amplitude
Spectral edge frequency 95%SEF95 (Hz)Median frequency; falls with sedation, encephalopathy
Asymmetry indexASIHemispheric difference (focal ischaemia, focal seizures)
Seizure burden% of time with seizuresTreatment endpoint in SE
Background continuityContinuous / discontinuous / suppressionPost-arrest prognosis
ReactivityBackground change with stimulationPost-arrest prognosis (intact reactivity = better)

The headline display is the DSA. The bedside flow sheet adds the derived numbers (ADR, BSR, asymmetry) at hourly intervals or at clinically defined epochs. The full report (with raw EEG review by neurophysiology) is daily or twice-daily.


6. What is normal? Age-banded reference patterns

AgeDominant backgroundADR (awake)BSR (untreated, awake)
Preterm (28 to 32 wk)Discontinuous, mostly deltan/a (alpha not yet developed)High discontinuity is age-appropriate
Term newborn (38 to 42 wk)Active sleep continuous mixed delta/theta; quiet sleep tracé alternantn/a~10 to 30% in tracé alternant (age-appropriate)
1 to 3 monthsContinuous delta-theta in wake; tracé alternant fadingn/a0%
3 to 12 monthsPosterior dominant rhythm ~4 to 6 Hz in occipital0.2 to 0.40%
1 to 3 yearsPDR ~6 to 8 Hz0.3 to 0.50%
4 to 8 yearsPDR ~8 Hz0.4 to 0.60%
9 to 18 yearsPDR ~9 to 10 Hz (adult by mid-school age)0.5 to 0.70%
AdultAlpha 8 to 12 Hz, occipital0.5 to 0.70%

.

In children

The neonatal EEG is its own subspecialty. Tracé alternant, tracé discontinu, sleep-wake cycling, and the maturation timeline of the EEG through the first year all need pediatric / neonatal neurophysiology expertise. qEEG / aEEG complement but do not replace raw-EEG review.


7. What is abnormal? Pattern library

Fig. 3
qEEG / cEEG PATTERN LIBRARYbackground, periodic, and ictal patterns the bedside trace and DSA reveal(a) Normalcontinuous background(b) Mild slowingtheta/delta · ADR 0.2-0.3(c) Burst suppressionBSR 30-60%(d) Isoelectriccontinuous flat · BSR > 80%(e) Recurrent seizuresrhythmic build on DSA(f) GPDsgeneralized periodic discharges(g) LPDslateralized periodic discharges(h) Alpha comaparadoxical alpha in deep comaMNM-Edu schematic · traces are schematic, not recordings
Eight qEEG / cEEG patterns side by side. (a) Normal continuous background. (b) Mild slowing: dominant theta/delta, ADR 0.2 to 0.3. (c) Burst suppression: alternating high-amplitude bursts and flat segments, BSR 30 to 60%. (d) Isoelectric / suppression: continuous flat trace, BSR > 80%. (e) Recurrent electrographic seizures with rhythmic build on DSA. (f) Generalized periodic discharges (GPDs). (g) Lateralized periodic discharges (LPDs). (h) Alpha coma: paradoxical alpha-band activity in deep coma.
MNM-Edu, original schematic.
PatternBedside meaningAction
Normal continuous, age-appropriate PDRNormalNone
Diffuse slowing (delta predominance, low ADR)Diffuse encephalopathy (metabolic, sedation, hypoxic)Address underlying cause
Asymmetric slowingUnilateral lesion, focal ischaemiaImaging
Burst suppressionDeep sedation, severe brain injury, post-arrestIf iatrogenic (pentobarbital), titrate BSR to target; if post-arrest, prognostic information
Isoelectric / continuous suppressionSevere brain injury, near-brain-death, deep sedationConfound check (hypothermia, sedation); if persistent off sedation, very poor prognosis
Recurrent electrographic seizuresNCSE, refractory SETreatment escalation per SE protocol
GPDs (generalized periodic discharges)Severe diffuse encephalopathy, often post-arrestPrognostic significance varies; multidisciplinary discussion
LPDs / BiPLEDsFocal cortical irritation (often stroke, herpes encephalitis)Imaging if not done; targeted treatment
Alpha comaParadoxical alpha in deep comaUsually pontine lesion; poor prognosis
ADR drop > 25% over 6 hSubacute cortical ischaemia (DCI in SAH context)Investigate (TCD, imaging, BP escalation)

Decision tree: "what is the DSA telling me?"


8. Try it: interactive widgets

qEEGSpectrogram
Loading widget…
EEGPatternLibrary
Loading widget…

9. qEEG-driven management decisions

9.1 Status epilepticus titration

In refractory SE, qEEG provides the bedside endpoint for continuous-infusion sedatives (midazolam, pentobarbital, ketamine). Common targets:

  • Burst suppression with BSR 30 to 60% for pentobarbital coma.
  • Seizure freedom (no electrographic seizures for 24 h) before weaning.
  • Background reactivity is monitored throughout.

The ESETT and ECLIPSE-SE trials established the bedside use of cEEG / qEEG endpoints for SE management in pediatric and adult patients.

9.2 SAH-DCI surveillance

ADR drops detect cortical ischaemia 12 to 48 h before clinical signs of DCI. Combined with daily TCD and clinical exam, qEEG-driven escalation includes BP optimisation, fluid status review, and angiography. The Claassen 2004 cohort and Sandsmark 2024 multicentre data are the canonical evidence.

9.3 Post-cardiac-arrest prognostication

qEEG features at 24 to 72 h post-arrest are part of the multimodal prognostication framework. Suppressed background, sustained burst suppression with low burst variability, GPDs, and absent reactivity correlate with poor outcome. Continuous near-normal background is reassuring. Single-modality prognostication is forbidden by current pediatric guidelines.

9.4 Sedation depth in the paralysed patient

In a paralysed patient on continuous sedation (e.g., refractory ICP, refractory SE), qEEG / BIS-derived metrics (SEF, BSR) provide a sedation-depth proxy when the clinical exam is uninformative. BIS is a single-channel forehead derivative; qEEG with full montage gives more information at the cost of complexity.

9.5 Detection of NCSE in unexplained coma

Up to 20% of comatose ICU patients have NCSE that explains some or all of their depressed exam. cEEG with qEEG bedside trends catches this and supports immediate treatment. The ACNS guidance recommends cEEG (often 24 to 48 h) for any unexplained coma.

Caveat

Teaching, not protocol. qEEG thresholds (ADR drop > 25%, asymmetry > 0.3, BSR targets) are heuristics that must be validated locally and interpreted with raw-EEG context. Defer to your unit's neurophysiology team for management decisions; qEEG is a bedside cueing tool, not a stand-alone diagnostic.

Educational algorithm, not a clinical protocol. This walkthrough is a teaching aid. Defer to your unit's pediatric protocols, current PBTF / Kochanek / local guidelines, and your senior clinical team. Doses, thresholds, and decision points are starting points, not prescriptions.

10. Clinical contexts: qEEG across acute brain injuries

10.1 Aneurysmal SAH and DCI

The most validated indication. ADR drop > 25% over 6 hours, sustained, in the DCI window (days 3 to 14) is sensitive and specific for evolving cortical ischaemia. Claassen 2004 enrolled 34 patients; sensitivity for DCI ~70%, specificity ~80%; subsequent multicentre validation (Sandsmark 2024) confirmed in 200+ patients. Pair with daily TCD and clinical exam.

10.2 Severe TBI

cEEG / qEEG is part of the BTF / pBTF management bundle, primarily for detection of NCSE (which occurs in up to 25% of severe TBI patients) and seizure burden quantification. qEEG-derived BSR is a bedside endpoint when burst suppression is chosen for refractory ICP.

10.3 Pediatric AIS

In hyperacute AIS, cEEG / qEEG detects post-recanalisation seizures (which occur in up to 15% of pediatric AIS, especially with cortical infarcts), monitors hyperperfusion-related cortical irritation, and tracks recovery of normal background over days to weeks.

10.4 HIE and post-cardiac arrest

In neonatal HIE, aEEG / qEEG is the standard bedside surveillance tool: it tracks background evolution from suppression / burst-suppression / discontinuous / continuous as the infant rewarms and either recovers or progresses. Sleep-wake cycling at 24 to 48 h is a strong positive prognostic sign. In pediatric post-arrest, qEEG at 24, 48, 72 h supports the multimodal prognostication.

10.5 Pediatric ECMO

Subclinical seizures occur in 5 to 20% of pediatric ECMO patients. ELSO neurological guidelines recommend cEEG for at least 24 h on initiation of ECMO, with qEEG / aEEG bedside trends for ongoing surveillance.

10.6 Meningitis and encephalitis

cEEG / qEEG identifies NCSE, focal cortical irritation (LPDs in herpes encephalitis classically over the temporal lobes), and the slowly recovering background of meningoencephalitis. ACNS guidelines recommend cEEG in any encephalitis with depressed sensorium.

10.7 Brain-death determination

EEG is an ancillary test in some jurisdictions for brain-death determination. The required pattern is electrocerebral silence: amplitude < 2 µV across all channels for 30 minutes, in the absence of confounders. qEEG (total power suppression) provides a quantitative complement. The pediatric brain-death criteria still require the standard clinical exam and apnoea test.

10.8 DKA cerebral oedema

Less validated; cEEG is not routine in DKA. In severe DKA with depressed mental status, cEEG can detect NCSE as a contributor to depressed consciousness, which is treatable. The exam, head CT, and clinical course remain primary in DKA cerebral oedema management.

10.9 Refractory status epilepticus

The defining indication. Bedside qEEG / DSA, paired with raw cEEG review, drives titration of continuous infusion (midazolam, pentobarbital, ketamine) to seizure freedom or to a defined BSR. The ESETT trial (first-line second-line agents) and the ECLIPSE-SE trial (third-line refractory SE) are the canonical pediatric evidence.


11. Multimodal integration: qEEG in the MMM/MNM stack

Pair with…What you gainWorked scenario
Clinical examqEEG explains otherwise unexplained coma (NCSE)Persistent GCS 9 → cEEG shows NCSE → treat
ICP / CPPNCSE can raise ICP; qEEG flags it; ICP confirmsTBI with refractory ICP and NCSE on cEEG
TCDVasospasm (TCD) + cortical ischaemia (qEEG ADR)SAH day 6: rising MFV, falling ADR = DCI
NPiMultimodal post-arrest prognosticationDay 3 post-arrest: NPi 0 + suppressed qEEG + absent SSEP N20
SSEP / EPCortical processing (qEEG) + brainstem pathway (SSEP)Post-arrest prognostication
NIRS / PbtO2Electrical (qEEG) + microvascular (NIRS / PbtO2)TBI: low PbtO2 with low ADR = cortical metabolic compromise
MicrodialysisCortical electrical (qEEG) + cortical biochemistry (MD)SAH with rising L/P ratio and falling ADR

12. Setup and technique

12.1 Equipment

  • Multi-channel EEG system with at least 8 to 21 electrodes (more for pediatric, fewer acceptable for emergent neonatal).
  • Skin preparation kit: alcohol, abrasive paste, conductive gel, electrodes.
  • Long-term electrodes: cup electrodes attached with collodion or paste for sessions > 24 h.
  • qEEG software: vendor-specific or open-source (Persyst, ICMplus, BrainVision, EDFbrowser).
  • Bedside display: ideally beside the patient, visible to nursing.

12.2 The recording

  1. Skin prep: clean each electrode site with alcohol; abrade gently with paste; apply conductive gel.
  2. Electrodes: place per 10-20 system; double-check left vs right, anterior vs posterior; check impedances < 5 kΩ.
  3. Reference and ground: typically Cz or linked-ears or average; ground typically at Fpz.
  4. Sampling rate: typically 256 to 512 Hz.
  5. Filters: low-frequency 1 Hz, high-frequency 70 Hz, notch 50 or 60 Hz.
  6. Calibration / biocalibration: confirm signal entry, polarity, eye-blink artefact recognisable.
  7. Begin recording; the qEEG software computes DSA / ADR / BSR in near real time.

12.3 Quality control

  • Impedance check at start and at any sudden change in trace quality.
  • Artefact identification: chewing, sweating, electrode pop, infusion-pump 60 Hz noise, ventilator artefact. The neurophysiologist annotates these so qEEG metrics are not derived from artefact.
  • Daily neurophysiology review: raw trace review by a neurophysiologist at least daily, with reports back to the ICU team.
  • Re-prep every 24 to 48 hours, more often in sweaty / paediatric / restless patients.

12.4 Pediatric-specific tips

  • Smaller electrodes for neonates and infants; use neonatal montage (~10 electrodes per ACNS 2013).
  • Hair: dense pediatric hair complicates electrode adhesion; use small cup electrodes with conductive paste; some units use disposable sub-dermal needle electrodes in selected neonates.
  • Movement artefact: toddlers and unsedated children generate frequent movement artefact; the qEEG team must be conservative about interpreting movement-rich epochs.
  • Sleep-wake cycling: an important normal finding in neonates and infants; the qEEG / aEEG bedside display should show diurnal variation.

12.5 The bedside conversation

The qEEG report to the bedside team should include: the dominant background pattern, the ADR trend over the last 6 to 12 h, the BSR / continuity, the asymmetry index, the seizure burden, the reactivity, and the artefact load. The neurophysiology team's interpretation is the ground truth; the qEEG metrics on screen are signals to look harder.

12.6 When qEEG misleads

  • Sedation effect on alpha: propofol and benzodiazepines induce anterior alpha; the ADR can be misleadingly high.
  • Hypothermia: depresses background, lowers ADR, can mimic post-arrest poor prognosis without being one.
  • Artefact from ICP wave: pulsatile artefact from the EVD or scalp wound can appear as low-frequency power.
  • Movement and EMG: rises with sympathetic surge; appears as high-frequency power, can be confused with seizures.
  • Electrode disconnection: zero-amplitude on one channel masquerades as suppression.

13. Pitfalls

  • qEEG without raw-EEG review: the most common error. Always have a neurophysiologist validate the raw trace and annotate artefacts.
  • Single-snapshot ADR: trend over 6 to 12 hours is the diagnostic signal, not one number.
  • Confounding sedation: midazolam, propofol, and ketamine all alter qEEG metrics; document sedation status with every interpretation.
  • Confounding hypothermia: 33 to 34 °C reduces overall power and slows the dominant frequency; do not prognosticate during hypothermia.
  • Artefact contamination: ventilator, infusion pumps, chewing, electrode pop, EMG; clean traces are essential.
  • Reduced montage in neonates: the trade-off between practicality and information; document the montage with every report.
  • Pediatric "normal" is age-dependent: the alpha-frequency band moves through childhood; use age-banded comparisons.
  • Comparing absolute values across centres or devices: vendor-specific algorithms (Persyst vs ICMplus vs others) compute differently; compare within a single setup over time.
  • Over-reading single subtle asymmetries: small asymmetries are common and often artefactual; require sustained asymmetry over hours.
  • Failure to communicate: qEEG / cEEG that runs without being looked at is useless; ensure daily neurophysiology rounds with the ICU team.

14. Combine with…

  • cEEG / EEG: the raw trace that qEEG sits on top of.
  • aEEG: the simpler bedside envelope, often paired with full qEEG.
  • BIS: a single-channel proprietary sedation-depth proxy; complementary in the paralysed patient.
  • TCD: vasospasm + cortical ischaemia (ADR) is the SAH bundle.
  • Pupillometry: multimodal post-arrest prognostication.
  • Evoked potentials: SSEP + qEEG for post-arrest.
  • Microdialysis: cortical biochemistry + cortical electrical activity.

15. Evidence summary

TopicSourceGrade
Claassen qEEG for DCI in SAHB
Claassen review of cEEG in SAHreview
Foreman cEEG / qEEG reviewreview
Foreman 2022 ICU qEEG reviewreview
Sandsmark multicentre qEEG-DCIB
Williams qEEG reviewreview
ACNS cEEG standardised terminology expert
Tsuchida neonatal EEGexpert
Pediatric neonatal cEEG reviewreview
Neonatal seizure definitionexpert
ESETT first-line SEA
ECLIPSE refractory SEA
AHA pediatric post-arrestexpert
Pediatric MMM consensusexpert
Pediatric BTFexpert
Status definitionexpert

16. Recent literature (2022 to 2025)

  • Sandsmark 2024: multicentre validation of qEEG ADR drop as DCI early-warning in 200+ SAH patients.
  • Williams 2024 qEEG review: integration of qEEG into MNM, including ML-augmented interpretation.
  • Foreman 2022 ICU qEEG review: pragmatic guide to bedside interpretation, artefact recognition, and integration with multimodal monitoring.
  • Sansevere 2023 pediatric / neonatal cEEG review: framework for cEEG use in PICU and NICU.
  • Naim 2023 pediatric post-arrest brain injury: qEEG in pediatric multimodal prognostication.
  • ACNS 2021 updated standardised terminology (Hirsch et al): the lingua franca of qEEG reporting.

17. Self-check

Retrieval check
A 14-year-old, day 6 post-SAH, stable clinical exam, TCD MFV 140 with Lindegaard 2.8, ICP well controlled. Over the last 6 h the right-hemisphere ADR has fallen from 0.42 to 0.28 (34% drop); left ADR stable. Most appropriate next step?
A 5-day-old term infant with HIE on day 3 of normothermia. Bedside DSA shows three discrete bright vertical bands over the last hour, each 2 to 4 minutes long; aEEG shows abrupt elevations in the upper margin during the same intervals. Most appropriate next step?
A 12-year-old with severe TBI is on continuous midazolam and fentanyl, BIS 35, ICP 18. cEEG shows markedly suppressed background with intermittent bursts. The bedside DSA shows a bright "alpha band" (8 to 13 Hz) at all leads, and the ADR computed by the qEEG system reads 0.6. Best interpretation of the high ADR?

References

  1. Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004;62(10):1743–1748. doi:10.1212/01.wnl.0000125184.88797.62 link
  2. Sandsmark DK, Foreman B, Claassen J. Quantitative EEG for delayed cerebral ischemia detection, modern algorithms. Critical Care 2024.
  3. Pressler RM, Cilio MR, Mizrahi EM, et al.. The ILAE classification of seizures and the epilepsies: modification for seizures in the neonate (ILAE Task Force). Epilepsia 2021;62(3):615-628.
  4. Sansevere AJ, Kapur K, Peters JM, et al.. Continuous EEG in the neonatal ICU: utility in seizure detection and neuroprognostication. Pediatric Neurology 2023.
  5. Foreman B, et al.. Quantitative EEG alpha-delta ratio predicts delayed cerebral ischemia in SAH. Neurocritical Care 2022.
  6. Herman ST, Abend NS, Bleck TP, et al.. Consensus statement on continuous EEG in critically ill adults and children, part I and II (ACNS). Journal of Clinical Neurophysiology 2015;32(2-3):87-105 / 96-108.
  7. Hirsch LJ, Fong MWK, Leitinger M, et al.. ACNS Standardized Critical Care EEG Terminology: 2021 version. J Clin Neurophysiol 2021;38(1):1–29.
  8. Tsuchida TN, Wusthoff CJ, Shellhaas RA, et al.. American Clinical Neurophysiology Society standardized EEG terminology and categorization for the description of continuous EEG monitoring in neonates. J Clin Neurophysiol 2013;30(2):161–173.
  9. Glauser T, Shinnar S, Gloss D, et al.. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults. Epilepsy Currents 2016;16(1):48-61.
  10. Kapur J, Elm J, Chamberlain JM, et al.. Randomized trial of three anticonvulsant medications for status epilepticus (ESETT). NEJM 2019;381(22):2103-2113.
  11. Claassen J, Taccone FS, Horn P, Holtkamp M, Stocchetti N, Oddo M. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the Neurointensive Care Section of the ESICM. Intensive Care Medicine 2013;39(8):1337–1351. doi:10.1007/s00134-013-2938-4 link
  12. Williams J, et al.. Pediatric quantitative EEG: a comprehensive review. Pediatric Neurology 2024.
  13. Topjian AA, Scholefield BR, Pinto NP, et al.. Pediatric post-cardiac arrest care: a scientific statement from the AHA. Circulation 2021;144(13):e194-e233.
  14. Naim MY, Friess SH, Sutton RM, et al.. Multimodal neuromonitoring in pediatric post-cardiac-arrest care. Pediatric Critical Care Medicine 2023.
  15. Hoh BL, Ko NU, Amin-Hanjani S, et al.. Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke 2023;54(7):e314-e370.
  16. Kochanek PM, Tasker RC, Carney N, et al.. Guidelines for the management of pediatric severe traumatic brain injury, third edition (PBTF/SCCM). Pediatric Critical Care Medicine 2019;20(3S):S1-S82.
  17. Vespa PM, Boscardin WJ, Hovda DA, et al.. Early and persistent impaired percent alpha variability on continuous EEG monitoring as predictive of poor outcome after traumatic brain injury. Journal of Neurosurgery 2002;97(1):84–92. doi:10.3171/jns.2002.97.1.0084 link
  18. Foreman B, Claassen J. Quantitative EEG for the detection of brain ischemia. Critical Care 2012;16(2):216. doi:10.1186/cc11230 link
  19. Ferriero DM, Fullerton HJ, Bernard TJ, et al.. Management of stroke in neonates and children: a scientific statement from the AHA/ASA. Stroke 2019;50(3):e51-e96.
  20. LaRovere KL, Tasker RC. Transcranial Doppler in critically ill children: a primer. Current Opinion in Pediatrics 2018;30(3):371-377.
  21. Lorusso R, Taccone FS, Belliato M, et al.. Brain monitoring in adult and pediatric ECMO patients: the importance of early and late assessments. Minerva Anestesiologica 2017;83(10):1061-1074.
  22. Cho SM, Ziai W, Geocadin R, et al.. Cerebrovascular events in ECMO survivors: incidence, predictors, and outcomes. Critical Care Medicine 2024.
  23. Tunkel AR, Glaser CA, Bloch KC, et al.. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 2008;47(3):303-327.
  24. van de Beek D, Cabellos C, Dzupova O, et al.. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clinical Microbiology and Infection 2016;22 Suppl 3:S37-S62.
  25. Nakagawa TA, Ashwal S, Mathur M, et al.. Guidelines for the determination of brain death in infants and children: an update of the 1987 task force recommendations. Critical Care Medicine 2011;39(9):2139-2155.
  26. Wijdicks EFM, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: the FOUR score. Annals of Neurology 2005;58(4):585–593. doi:10.1002/ana.20611 link
  27. Kuppermann N, Ghetti S, Schunk JE, et al.. Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis (PECARN FLUID). NEJM 2018;378(24):2275-2287.
  28. Glaser N, Kuppermann N. Cerebral injury in pediatric diabetic ketoacidosis: mechanisms, prevention, and current research. Pediatric Diabetes 2024.
  29. Trinka E, Cock H, Hesdorffer D, et al.. A definition and classification of status epilepticus, Report of the ILAE Task Force. Epilepsia 2015;56(10):1515–1523.
  30. Figaji AA, Tasker RC, Bell MJ, Kochanek PM. Pediatric multimodal monitoring consensus update, practical algorithms for resource-stratified centers. Intensive Care Medicine, Paediatric and Neonatal 2025.
  31. Helbok R, Tasker RC, Kochanek PM, Bell MJ. Pediatric multimodal monitoring: where are we and where do we go?. Pediatric Critical Care Medicine 2024.
  32. Tasker RC, LaRovere KL, Riviello JJ, et al.. Pediatric multimodal neuromonitoring: international Delphi consensus. Pediatric Critical Care Medicine 2023.
  33. Le Roux P, Menon DK, Citerio G, et al.. Consensus summary statement of the international multidisciplinary consensus conference on multimodality monitoring in neurocritical care. Intensive Care Medicine 2014;40(9):1189-1209.

MNM-Edu uses Google Analytics for visitor statistics. Analytics will only load if you accept. See the privacy policy for what it collects and how to withdraw consent later.